Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VSL#3 for Maintenance of Remission in Ulcerative Colitis
NCT03415711Phase 2Terminated
- Sponsor
- VSL Pharmaceuticals, Inc.
- Start
- Apr 2017
- Primary completion
- Apr 2019
- Modality
- Multi-strain Products
- Countries
- 1
01
Overview
A Phase 2 trial of VSL#3 in ulcerative colitis (UC), sponsored by VSL Pharmaceuticals, Inc.. Started Apr 2017; status: terminated.
02
Drugs
VSL#3
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT03415711.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03415711.